1. Home
  2. MNOV vs STIM Comparison

MNOV vs STIM Comparison

Compare MNOV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNOV
  • STIM
  • Stock Information
  • Founded
  • MNOV 2000
  • STIM 2003
  • Country
  • MNOV United States
  • STIM United States
  • Employees
  • MNOV N/A
  • STIM N/A
  • Industry
  • MNOV Biotechnology: Pharmaceutical Preparations
  • STIM Medical/Dental Instruments
  • Sector
  • MNOV Health Care
  • STIM Health Care
  • Exchange
  • MNOV Nasdaq
  • STIM Nasdaq
  • Market Cap
  • MNOV 91.7M
  • STIM 192.0M
  • IPO Year
  • MNOV 2005
  • STIM 2018
  • Fundamental
  • Price
  • MNOV $1.84
  • STIM $3.98
  • Analyst Decision
  • MNOV Strong Buy
  • STIM Buy
  • Analyst Count
  • MNOV 1
  • STIM 4
  • Target Price
  • MNOV $9.00
  • STIM $4.67
  • AVG Volume (30 Days)
  • MNOV 20.1K
  • STIM 1.6M
  • Earning Date
  • MNOV 02-18-2025
  • STIM 03-04-2025
  • Dividend Yield
  • MNOV N/A
  • STIM N/A
  • EPS Growth
  • MNOV N/A
  • STIM N/A
  • EPS
  • MNOV N/A
  • STIM N/A
  • Revenue
  • MNOV N/A
  • STIM $72,711,000.00
  • Revenue This Year
  • MNOV N/A
  • STIM $3.23
  • Revenue Next Year
  • MNOV N/A
  • STIM $29.55
  • P/E Ratio
  • MNOV N/A
  • STIM N/A
  • Revenue Growth
  • MNOV N/A
  • STIM 5.03
  • 52 Week Low
  • MNOV $1.12
  • STIM $0.52
  • 52 Week High
  • MNOV $2.55
  • STIM $5.07
  • Technical
  • Relative Strength Index (RSI)
  • MNOV 39.12
  • STIM 70.68
  • Support Level
  • MNOV $1.83
  • STIM $2.80
  • Resistance Level
  • MNOV $1.97
  • STIM $3.65
  • Average True Range (ATR)
  • MNOV 0.07
  • STIM 0.44
  • MACD
  • MNOV -0.01
  • STIM 0.06
  • Stochastic Oscillator
  • MNOV 8.33
  • STIM 98.49

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

Share on Social Networks: